Merck Global Health Innovation (Merck GHI)
Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.
Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.
With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck’s expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.
BiM-Mitglied: Marc Sluijs, Digital health investment advisory
Genf und Umgebung, Schweiz
Marc is currently advising large investors with regards to investment in digital health growth companies. Marc has 20 years of experience working with the Life Sciences industry, information enabled business models (IMS Health), Life Sciences management consulting (Accenture), and biotech (MerckSerono). Most recently, Marc was responsible for M&A and digital health partnerships at Oracle Health Sciences, where his involvement ranged from projects such as the acquisition of ClearTrial and the partnership with Greenphire to Oracle’s investment in Proteus Digital Health.